[ORGANIZATION]
Asundexian
Featured in 2 tracked stories · first seen
Situations
Bayer Asundexian regulatory approvals
2 clusters · 10 sources · last updated
Latest: Bayer receives FDA approval for Sunharbo stroke prevention drug
Bayer has received regulatory approvals for its blood thinner, asundexian, marketed under the brand name Sunharbo. The medication is a factor XIa inhibitor designed to reduce the risk of recurrent ischemic stroke. In Oc
Bayer pharmaceutical and financial outlook
4 clusters · 24 sources · last updated
Latest: Bayer stock reaches new yearly high amid legal relief
Bayer is facing investor scrutiny regarding its ability to balance pharmaceutical innovation with financial performance. In mid October, the company saw progress in its drug development pipeline, specifically with the FD